Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited tumor-infiltrating lymphocytes (TILs) may be ...

New Delhi, May 3 (IANS): The CRISPR/Cas9 gene-editing technique has shown promise in fighting advanced colorectal cancer, ...

The CRISPR/Cas9 gene-editing technique has shown promise in fighting advanced colorectal cancer, according to results of the ...

The FDA has cleared investigational new drug applications and handed out fast track designations. Plus, data shows promise for novel therapies in hard-to-treat cancers.

The team used CRISPR-Cas9 to reduce the level of asparagine ... risk assessments and labelling requirements. Lukasiewicz explained that the primary difference between NGT 1 and NTG 2 lies in ...

Earlier, ToolGen registered a patent in Europe and Japan for a method of introducing 'Cas9'—a key component of CRISPR gene editing ... ToolGen explained that this patent infringement lawsuit ...

IO Biotech's first-in-class vaccine performs double duty, killing cancer cells and enhancing the tumor microenvironment. A ...

For decades, scientists and surgeons around the world have been trying to solve the organ donor crisis. The answer could be ...

or the host DNA-repair system,” explained Frank Buchholz, PROVIREX co-founder, and professor of medical systems biology and dean of research at the Medical Faculty Carl Gustav Carus of the ...